Cargando…

Surgical management of pulmonary inflammatory pseudotumors: A single center experience

BACKGROUND: The pulmonary inflammatory pseudotumor (PIP) is a rare disease. It is still debated whether it represents an inflammatory lesion characterized by uncontrolled cell growth or a true neoplasm. PIP is characterized by a cellular polymorphism. METHODS: We retrospectively analyzed 8 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondello, Baldassare, Lentini, Salvatore, Barone, Mario, Barresi, Pietro, Monaco, Francesco, Familiari, Dario, La Rocca, Annunziata, Sibilio, Michele, Acri, Ignazio Eduardo, David, Antonio, Monaco, Maurizio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049133/
https://www.ncbi.nlm.nih.gov/pubmed/21345228
http://dx.doi.org/10.1186/1749-8090-6-18
_version_ 1782199209081962496
author Mondello, Baldassare
Lentini, Salvatore
Barone, Mario
Barresi, Pietro
Monaco, Francesco
Familiari, Dario
La Rocca, Annunziata
Sibilio, Michele
Acri, Ignazio Eduardo
David, Antonio
Monaco, Maurizio
author_facet Mondello, Baldassare
Lentini, Salvatore
Barone, Mario
Barresi, Pietro
Monaco, Francesco
Familiari, Dario
La Rocca, Annunziata
Sibilio, Michele
Acri, Ignazio Eduardo
David, Antonio
Monaco, Maurizio
author_sort Mondello, Baldassare
collection PubMed
description BACKGROUND: The pulmonary inflammatory pseudotumor (PIP) is a rare disease. It is still debated whether it represents an inflammatory lesion characterized by uncontrolled cell growth or a true neoplasm. PIP is characterized by a cellular polymorphism. METHODS: We retrospectively analyzed 8 patients with PIP treated by surgery between 2001 and 2009. Preoperative thoracic computed tomography (CT) scan was performed in all cases. All patients underwent preoperative bronchoscopy with washing and brushing and/or transbronchial biopsy and preoperative cytology examination RESULTS: There were 5 men and 3 women, aged between 38 and 69 years (mean of 58 years). 3 patients (37%) were asymptomatic. The others had symptoms characterized by chest pain, shortness of breath and persistent cough or hemoptysis. 5 patients had neutrophilic leucocytosis. CT scan demonstrated solitary nodules (maximum diameter <3 cm) in 5 patients (62%) and lung masses (maximum diameter >3 cm) in 3 patients (37%). In 2 patients there were signs of pleural infiltration. Distant lesions were excluded in all cases. A preoperative histology examination failed to reach a definitive diagnosis in all patients. At surgery, we performed two lobectomies, one segmentectomy and five wedge resections, these being performed with videothoracoscopy (VATS), except for one patient where open surgery was used. Complete tumor resection was obtained in all patients. According to the Matsubara classification, there were 2 cases of organizing pneumonia, 5 cases of fibrous histiocytoma and one case of lymphoplasmacytoma. All patients were discharged alive from hospital between 4 and 7 days after surgery. At follow-up CT scan performed annually (range 11 to 112 months) (mean 58 months), there were no residual lesions, neither local nor distant recurrences. CONCLUSIONS: PIP is a rare disease. Many synonyms have been used for this disease, usually in relation to the most represented cell type. The true incidence is unclear. Preoperative diagnosis is difficult to reach, despite performing a bronchoscopy or a transparietal needle aspiration. Different classifications have been proposed for PIP. Either medical, radiation or surgical therapy has been used for PIP. Whenever possible, surgery should be considered the standard treatment. Complete surgical resection is advocated to prevent recurrence.
format Text
id pubmed-3049133
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30491332011-03-06 Surgical management of pulmonary inflammatory pseudotumors: A single center experience Mondello, Baldassare Lentini, Salvatore Barone, Mario Barresi, Pietro Monaco, Francesco Familiari, Dario La Rocca, Annunziata Sibilio, Michele Acri, Ignazio Eduardo David, Antonio Monaco, Maurizio J Cardiothorac Surg Research Article BACKGROUND: The pulmonary inflammatory pseudotumor (PIP) is a rare disease. It is still debated whether it represents an inflammatory lesion characterized by uncontrolled cell growth or a true neoplasm. PIP is characterized by a cellular polymorphism. METHODS: We retrospectively analyzed 8 patients with PIP treated by surgery between 2001 and 2009. Preoperative thoracic computed tomography (CT) scan was performed in all cases. All patients underwent preoperative bronchoscopy with washing and brushing and/or transbronchial biopsy and preoperative cytology examination RESULTS: There were 5 men and 3 women, aged between 38 and 69 years (mean of 58 years). 3 patients (37%) were asymptomatic. The others had symptoms characterized by chest pain, shortness of breath and persistent cough or hemoptysis. 5 patients had neutrophilic leucocytosis. CT scan demonstrated solitary nodules (maximum diameter <3 cm) in 5 patients (62%) and lung masses (maximum diameter >3 cm) in 3 patients (37%). In 2 patients there were signs of pleural infiltration. Distant lesions were excluded in all cases. A preoperative histology examination failed to reach a definitive diagnosis in all patients. At surgery, we performed two lobectomies, one segmentectomy and five wedge resections, these being performed with videothoracoscopy (VATS), except for one patient where open surgery was used. Complete tumor resection was obtained in all patients. According to the Matsubara classification, there were 2 cases of organizing pneumonia, 5 cases of fibrous histiocytoma and one case of lymphoplasmacytoma. All patients were discharged alive from hospital between 4 and 7 days after surgery. At follow-up CT scan performed annually (range 11 to 112 months) (mean 58 months), there were no residual lesions, neither local nor distant recurrences. CONCLUSIONS: PIP is a rare disease. Many synonyms have been used for this disease, usually in relation to the most represented cell type. The true incidence is unclear. Preoperative diagnosis is difficult to reach, despite performing a bronchoscopy or a transparietal needle aspiration. Different classifications have been proposed for PIP. Either medical, radiation or surgical therapy has been used for PIP. Whenever possible, surgery should be considered the standard treatment. Complete surgical resection is advocated to prevent recurrence. BioMed Central 2011-02-23 /pmc/articles/PMC3049133/ /pubmed/21345228 http://dx.doi.org/10.1186/1749-8090-6-18 Text en Copyright ©2011 Mondello et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mondello, Baldassare
Lentini, Salvatore
Barone, Mario
Barresi, Pietro
Monaco, Francesco
Familiari, Dario
La Rocca, Annunziata
Sibilio, Michele
Acri, Ignazio Eduardo
David, Antonio
Monaco, Maurizio
Surgical management of pulmonary inflammatory pseudotumors: A single center experience
title Surgical management of pulmonary inflammatory pseudotumors: A single center experience
title_full Surgical management of pulmonary inflammatory pseudotumors: A single center experience
title_fullStr Surgical management of pulmonary inflammatory pseudotumors: A single center experience
title_full_unstemmed Surgical management of pulmonary inflammatory pseudotumors: A single center experience
title_short Surgical management of pulmonary inflammatory pseudotumors: A single center experience
title_sort surgical management of pulmonary inflammatory pseudotumors: a single center experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049133/
https://www.ncbi.nlm.nih.gov/pubmed/21345228
http://dx.doi.org/10.1186/1749-8090-6-18
work_keys_str_mv AT mondellobaldassare surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT lentinisalvatore surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT baronemario surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT barresipietro surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT monacofrancesco surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT familiaridario surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT laroccaannunziata surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT sibiliomichele surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT acriignazioeduardo surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT davidantonio surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience
AT monacomaurizio surgicalmanagementofpulmonaryinflammatorypseudotumorsasinglecenterexperience